Showing 2221-2230 of 21409 results for "".
- Innovative Pain Management in Anesthesiology: Adenosine and Non-Opioid Alternativeshttps://reachmd.com/news/innovative-pain-management-in-anesthesiology-adenosine-and-non-opioid-alternatives/2475807/Despite ongoing breakthroughs in anesthesiology, achieving potent analgesia while minimizing adverse effects remains an underrecognized challenge, driving interest in adenosine and other non-opioid modalities to reshape perioperative pain control. The quest to balance effective pain
- Transformative Vaccination Advances: Impact on RSV and mRNA Platformshttps://reachmd.com/news/transformative-vaccination-advances-impact-on-rsv-and-mrna-platforms/2475802/With rapid breakthroughs in vaccine technology, recent developments in maternal RSV immunization and mRNA platform enhancements are transforming neonatal care by significantly reducing respiratory morbidity and improving vaccine safety profiles. Preventing severe respiratory infectio
- Enhancing Prostate Cancer Imaging with Ultrasound-to-MRI Translation Technologieshttps://reachmd.com/news/enhancing-prostate-cancer-imaging-with-ultrasound-to-mri-translation-technologies/2475789/Ultrasound alone can fail to detect a substantial subset of clinically significant prostate tumors, leading to diagnostic uncertainty and treatment delays. Relying solely on transrectal ultrasound for prostate cancer imaging has long posed a challenge for urologists and radiologists,
- Recalibrating Primary Care: Addressing Obesity in Aging with Integrated Lifestyle Interventionshttps://reachmd.com/news/recalibrating-primary-care-addressing-obesity-in-aging-with-integrated-lifestyle-interventions/2475780/The paradox of rising obesity amid economic prosperity—fueled by a shift toward ultra-processed foods—demands a new primary care approach that weaves together dietary and exercise interventions to manage weight and preserve vitality in older adults. Cross-national analyses reveal tha
- PSMA PET/CT Imaging and the Future of Prostate and Bladder Cancer Detectionhttps://reachmd.com/news/psma-petct-imaging-and-the-future-of-prostate-and-bladder-cancer-detection/2475781/Prostate cancer’s heterogeneity and the blind spots of conventional imaging often obscure disease extent, leaving clinicians caught between undertreatment and unnecessary morbidity; now, radiolabeled PSMA PET/CT imaging is enhancing detection accuracy and treatment precision, though
- The FDA Approval of Inebilizumab for IgG4-Related Diseasehttps://reachmd.com/news/the-fda-approval-of-inebilizumab-for-igg4-related-disease/2475774/The FDA approval of Inebilizumab for IgG4-Related Disease marks a landmark in providing a targeted therapeutic option for a condition long underse
- Evolving Prostate Cancer Imaging: The Impact of PSMA PET/CT and New Techniqueshttps://reachmd.com/news/evolving-prostate-cancer-imaging-the-impact-of-psma-petct-and-new-techniques/2475753/Conventional imaging fails to detect micro-metastatic disease in up to 30% of patients with biochemical recurrence, delaying targeted intervention for prostate cancer. For the practicing urologist, equivocal findings on CT and bone scans represent a diagnostic blind
- Pulmonary Implications of Anti-SSB/La Antibodies in Sjögren’s Diseasehttps://reachmd.com/news/pulmonary-implications-of-anti-ssbla-antibodies-in-sjogrens-disease/2475758/Understanding the pulmonary implications of autoantibodies in Sjögren’s Disease has become paramount as emerging evidence highlights a link between anti-SSB/La positivity and reduced diffusing capacity for carbon monoxide (DLCO). The challenge of identifying early l
- AI and Pharmaceutical Innovations in Glaucoma Carehttps://reachmd.com/news/ai-and-pharmaceutical-innovations-in-glaucoma-care/2475751/Emerging technologies are reshaping the landscape of glaucoma care; however, AI-driven detection remains underutilized at the point where early intervention could prevent irreversible vision loss. Using glaucom
- New Genetic Insights in SCAD: Implications for Cardiology Practicehttps://reachmd.com/news/new-genetic-insights-in-scad-implications-for-cardiology-practice/2475752/In the evolving field of cardiology, new insights into genetic and familial factors are reshaping our understanding of Spontaneous Coronary Artery Dissection (SCAD), which accounts for approximately 1% to 4% of all ACS cas